On the Spotlight!

The Industrial Technology Development Institute (DOST-ITDI) , in its bid to contribute to industrialization and progress through R&D initiatives, will conduct a webcast for its newly opened Modular Multi-Industry Innovation Center (MMIC) or InnoHub sa Pinas on March 31, 2021. Following MMIC’s successful launch in December 2020 and inauguration in February 2021, ITDI once again invites industry partners and stakeholders to share their insights and expectations about the new facility. InnoHub sa Pinas is an industrial processing facility with multifunctional/multi-application modular unit operation equipment that can be retrofitted to accommodate different manufacturing lines. It is built to serve the needs of the food, personal care, and pharma-nutraceutical industries using its three main processing lines for nut/seed and oils, mix blend powders, and liquids/emulsions which rely mainly on by-products of commercial operations as raw material . In effect, new or novel products ...

Travelling becomes complicated ever since the Covid-19 pandemic hits the world. There have been so many requirements needed just to make sure that the traveler is covid-free and the community he/she will be visiting will be safe. In the Philippines, a “travel authority” is needed to be able to travel from one province to another. There are many requirements and travelers have a hard time getting one. The Department of Science and Technology developed the Safe, Swift and Smart Passage or S-PaSS , an innovative travel management system for local travelers, returning OFWs and Tourists. In light of the approval of the Inter-Agency Task Force (IATF) for the Management of Emerging Infectious Diseases Resolution #101 , on February 26, 2021, of the uniform travel protocols for all local government units (LGUs), the S-PaSS Travel Management System will now be institutionalized as the one-stop-shop application/communication for travelers. S-Pass was virtually launched last March 26 ...

The Philippine Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to Sputnik V , one of Russia’s COVID-19 vaccines, today, 19 March 2021, as announced by FDA Director General Eric Domingo during the Department of Health (DOH)’s Special Briefing. Vials labelled "Sputnik V Coronavirus COVID-19 Vaccine" are seen in this illustration photo taken March 12, 2021. REUTERS/Dado Ruvic/Illustration. Photo taken from Channelnewsasia.com Authorized for limited use among Filipino individuals aged 18 and above, the non-replicating viral vector COVID-19 vaccine was developed by the Gamaleya Research Institute of Epidemiology and Microbiology through the support of the Russian Direct Investment Fund (RDIF). Both Gamaleya and RDIF were identified by the Department of Science and Technology (DOST), which chairs the Task Group on Vaccine Evaluation and Selection (TG VES), as one of its bilateral partners for the possible conduct of vaccine clinical trials in the ...